Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Security class unavailable · CUSIP: 539319103

Event date: 2014-04-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.2800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-14-001398
Form type
SC 13G/A
Filer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK
CIK 1335105
Filed
May 12, 2014
Reporting period
Apr 28, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub